本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Quince Therapeutics, Inc.

29.55
+0.59002.04%
盤後29.550.00000.00%19:30 EDT
成交量:1.13萬
成交額:33.43萬
市值:3,005.53萬
市盈率:-0.32
高:30.44
開:28.88
低:28.88
收:28.96
52周最高:909.98
52周最低:15.10
股本:101.71萬
流通股本:67.97萬
量比:0.75
換手率:1.67%
股息:- -
股息率:- -
每股收益(TTM):-90.9250
每股收益(LYR):-335.2669
淨資產收益率:-153.84%
總資產收益率:-31.51%
市淨率:-0.85
市盈率(LYR):-0.09

資料載入中...

公司資料

公司名字:
Quince Therapeutics, Inc.
交易所:
NASDAQ
成立時間:
2012
員工人數:
38
公司地址:
611 Gateway Boulevard,Suite 273,South San Francisco,California,United States
郵編:
94080
電話:
傳真:
- -
簡介:
Quince Therapeutics, Inc.於2012年6月20日在特拉華州註冊成立。該公司是一家生物技術公司,在完成其3期NEAT試驗之前,專註於利用其專有的AIDE技術平台開發罕見病治療方法。

董事

名稱
職位
Dirk Thye
Chief Executive Officer and Chief Medical Officer and Director
Brigette Roberts
Chief of Corporate Affairs and Director
David A. Lamond
Chairperson of the Board and Director
Christopher J. Senner
Director
June Bray
Director

股東

名稱
職位
Dirk Thye
Chief Executive Officer and Chief Medical Officer and Director
Brendan Hannah
Chief Business Officer and Chief Compliance Officer and Chief Operating Officer
Brigette Roberts
Chief of Corporate Affairs and Director
Charles Ryan
President